These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28107841)

  • 1. Adeno-Associated Virus-Mediated Mini-Agrin Delivery Is Unable to Rescue Disease Phenotype in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2I.
    Vannoy CH; Zhou H; Qiao C; Xiao X; Bang AG; Lu QL
    Am J Pathol; 2017 Feb; 187(2):431-440. PubMed ID: 28107841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
    Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
    Thomas PJ; Xu R; Martin PT
    Am J Pathol; 2016 Sep; 186(9):2429-48. PubMed ID: 27561302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.
    Xu L; Lu PJ; Wang CH; Keramaris E; Qiao C; Xiao B; Blake DJ; Xiao X; Lu QL
    Mol Ther; 2013 Oct; 21(10):1832-40. PubMed ID: 23817215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
    Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
    J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mouse agrin in normal, denervated and dystrophic muscle.
    Eusebio A; Oliveri F; Barzaghi P; Ruegg MA
    Neuromuscul Disord; 2003 Jun; 13(5):408-15. PubMed ID: 12798796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation.
    Wu B; Shah SN; Lu P; Richardson SM; Bollinger LE; Blaeser A; Madden KL; Sun Y; Luckie TM; Cox MD; Sparks S; Harper AD; Lu QL
    Am J Pathol; 2016 Jun; 186(6):1635-48. PubMed ID: 27109613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
    Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
    Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.
    Qiao C; Wang CH; Zhao C; Lu P; Awano H; Xiao B; Li J; Yuan Z; Dai Y; Martin CB; Li J; Lu Q; Xiao X
    Mol Ther; 2014 Nov; 22(11):1890-9. PubMed ID: 25048216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.
    Qiao C; Li J; Zhu T; Draviam R; Watkins S; Ye X; Chen C; Li J; Xiao X
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):11999-2004. PubMed ID: 16103356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I.
    Azzag K; Ortiz-Cordero C; Oliveira NAJ; Magli A; Selvaraj S; Tungtur S; Upchurch W; Iaizzo PA; Lu QL; Perlingeiro RCR
    Skelet Muscle; 2020 Apr; 10(1):10. PubMed ID: 32321586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
    Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
    Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
    Bentzinger CF; Barzaghi P; Lin S; Ruegg MA
    FASEB J; 2005 Jun; 19(8):934-42. PubMed ID: 15923403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
    Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
    FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A.
    Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT
    Am J Pathol; 2007 Jul; 171(1):181-99. PubMed ID: 17591965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice.
    Zarén P; Gawlik KI
    Sci Rep; 2024 Jun; 14(1):14757. PubMed ID: 38926599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.
    Gicquel E; Maizonnier N; Foltz SJ; Martin WJ; Bourg N; Svinartchouk F; Charton K; Beedle AM; Richard I
    Hum Mol Genet; 2017 May; 26(10):1952-1965. PubMed ID: 28334834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
    Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
    Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.